Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
12.01. | VITURA HEALTH LIMITED: Update regarding TGA proceedings | - | ASX | ||
VITURA HEALTH Aktie jetzt für 0€ handeln | |||||
27.11.24 | VITURA HEALTH LIMITED: Initial Director's Interest Notice | - | ASX | ||
27.11.24 | VITURA HEALTH LIMITED: Initial Director's Interest Notice | - | ASX | ||
27.11.24 | VITURA HEALTH LIMITED: Results of 2024 Annual General Meeting | 2 | ASX | ||
26.11.24 | VITURA HEALTH LIMITED: Initial Director's Interest Notice | - | ASX | ||
26.11.24 | VITURA HEALTH LIMITED: Initial Director's Interest Notice | - | ASX | ||
26.11.24 | VITURA HEALTH LIMITED: Final Director's Interest Notice | - | ASX | ||
26.11.24 | VITURA HEALTH LIMITED: Final Director's Interest Notice | - | ASX | ||
26.11.24 | VITURA HEALTH LIMITED: Final Director's Interest Notice | - | ASX | ||
25.11.24 | VITURA HEALTH LIMITED: Presentation for 2024 AGM | - | ASX | ||
21.11.24 | VITURA HEALTH LIMITED: Proposed issue of securities - VIT | 3 | ASX | ||
21.11.24 | VITURA HEALTH LIMITED: Change in substantial holding | 2 | ASX | ||
19.11.24 | VITURA HEALTH LIMITED: Proposed issue of securities - VIT | - | ASX | ||
19.11.24 | VITURA HEALTH LIMITED: Vitura JV acquires assets of Releaf Group | 2 | ASX | ||
18.11.24 | VITURA HEALTH LIMITED: Cleansing Notice - section 708A(5) | - | ASX | ||
18.11.24 | VITURA HEALTH LIMITED: Application for quotation of securities - VIT | - | ASX | ||
29.10.24 | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
27.10.24 | VITURA HEALTH LIMITED: Strategy Reset delivers positive Q1 results | - | ASX | ||
25.10.24 | VITURA HEALTH LIMITED: Updated Proxy Form | - | ASX | ||
23.10.24 | VITURA HEALTH LIMITED: Shareholder statement | 2 | ASX |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
AURORA CANNABIS | 3,692 | -0,54 % | Aurora Cannabis Inc (3): Aurora Cannabis to release Q3 results Feb. 5 | ||
TILRAY BRANDS | 1,091 | +0,09 % | Trump jetzt am Drücker: Neue Hoffnungen für Tilray, Canopy & Co. oder droht der nächste Abverkauf? | © Foto: adobe.stock.comDer Amtsantritt Donald Trumps am gestrigen Montag schlug hohe Wellen. Seine Antrittsrede machte deutlich, dass sich Vieles ändern wird. Auch für den Cannabis-Sektor dürften es... ► Artikel lesen | |
ORGANIGRAM | 1,486 | -1,20 % | OrganiGram-Aktie: Warum Anleger jetzt genau hinschauen sollten | Im Schatten von Branchenriesen wie Tilray und Canopy Growth zeigt die Aktie des kanadischen Cannabis-Unternehmens OrganiGram in den letzten 4 Wochen klare Aufwärtstendenzen - und das nicht ohne Grund.... ► Artikel lesen | |
SNDL | 1,646 | -1,79 % | HYTN und SNDL streben Zusammenarbeit bei der Entwicklung von GMP-konformen Vape-Kartuschen für globale Märkte an | Vancouver, British Columbia - 21. Januar 2025 / IRW-Press / HYTN Innovations Inc. (CSE: HYTN, FWB: 85W0, OTC PINK: HYTNF) ("HYTN" oder das "Unternehmen"), ein Unternehmen, das sich auf die Herstellung... ► Artikel lesen | |
MYDECINE INNOVATIONS GROUP | 0,002 | 0,00 % | Mydecine Innovations Group Inc - Mydecine Announces Filing of Q3 Financial Statements | Mydecine Innovations Group Inc - Mydecine Announces Filing of Q3 Financial Statements
PR Newswire
LONDON, United Kingdom, November 21
MYDECINE ANNOUNCES FILING OF Q3 FINANCIAL... ► Artikel lesen | |
BIONANO GENOMICS | 0,186 | 0,00 % | Bionano Genomics: Bionano Announces Effective Date of Reverse Stock Split | SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO)(the "Company") today announced that it will effect a reverse stock split of its issued and outstanding common stock... ► Artikel lesen | |
TONIX PHARMACEUTICALS | 0,319 | 0,00 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia | Tonix received FDA's Day 74 Letter granting TNX-102 SL a Prescription Drug User Fee Act (PDUFA) goal date of August 15, 2025 TNX-102 SL is a non-opioid, centrally acting analgesic, granted Fast... ► Artikel lesen | |
HIGH TIDE | 2,935 | +1,56 % | High Tide Inc (2): High Tide to release fiscal 2024 results Jan. 29 | ||
JAGUAR HEALTH | 0,814 | 0,00 % | Jaguar Health, Inc.: Jaguar Health Announces First Patient Dosed in Investigator-Initiated Trial Evaluating Crofelemer for the Rare Disease Indication of Microvillus Inclusion Disease , with Proof-of-Concept Data Potentially Available H1 2025 | Trial taking place at Sheikh Khalifa Medical City, a flagship tertiary hospital in the United Arab EmiratesPOC data generated from this study could potentially lead to reimbursed early patient access... ► Artikel lesen | |
ACHIEVE LIFE SCIENCES | 2,885 | -2,70 % | ACHV-Aktie erreicht 52-Wochen-Tief bei 3,01 US-Dollar | ||
SEELOS THERAPEUTICS | 2,000 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.10.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 24.10.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.10.2024ISIN NameAU0000114977 BOOKTOPIA... ► Artikel lesen | |
MEDIPHARM LABS | 0,048 | +5,75 % | Medipharm Labs Corp: Medipharm extends closing of Napanee sale to Jan. 31 | ||
ARGENT BIOPHARMA | 0,110 | 0,00 % | ARGENT BIOPHARMA LIMITED: s708A Cleansing Notice | ||
AUSCANN | - | - | AUSCANN GROUP HOLDINGS LTD: Removal from Official List - Annual Listing Fees | ||
AYR WELLNESS | 0,452 | +8,26 % | CSE Bulletin: New Listing - Ayr Wellness Inc. 10DEC2026 13% Senior Secured Notes (AYR.NT.A.U) | Toronto, Ontario--(Newsfile Corp. - le 14 août/August 2024) - Ayr Wellness Inc. 10DEC2026 13% Senior Secured Notes have been approved for listing. See the Indenture for full details._________________________________... ► Artikel lesen |